On Friday, Fractyl Health Inc (NASDAQ: GUTS) opened lower -0.55% from the last session, before settling in for the closing price of $1.81. Price fluctuations for GUTS have ranged from $1.74 to $14.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 96.33% at the time writing. With a float of $20.64 million, this company’s outstanding shares have now reached $48.09 million.
In terms of profitability, gross margin is -47.42%, operating margin of -83816.49%, and the pretax margin is -64849.48%.
Fractyl Health Inc (GUTS) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Fractyl Health Inc is 57.09%, while institutional ownership is 35.93%. The most recent insider transaction that took place on Nov 11 ’24, was worth 238,358. In this transaction Chief Executive Officer of this company sold 96,517 shares at a rate of $2.47, taking the stock ownership to the 491,329 shares. Before that another transaction happened on Nov 11 ’24, when Company’s President, Chief Product Off. sold 64,197 for $2.47, making the entire transaction worth $158,541. This insider now owns 153,544 shares in total.
Fractyl Health Inc (GUTS) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 96.33% per share during the next fiscal year.
Fractyl Health Inc (NASDAQ: GUTS) Trading Performance Indicators
Check out the current performance indicators for Fractyl Health Inc (GUTS). In the past quarter, the stock posted a quick ratio of 5.57. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 865.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.16, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -2.55 in one year’s time.
Technical Analysis of Fractyl Health Inc (GUTS)
Fractyl Health Inc (NASDAQ: GUTS) saw its 5-day average volume 0.61 million, a positive change from its year-to-date volume of 0.42 million. As of the previous 9 days, the stock’s Stochastic %D was 9.07%. Additionally, its Average True Range was 0.17.
During the past 100 days, Fractyl Health Inc’s (GUTS) raw stochastic average was set at 2.54%, which indicates a significant decrease from 6.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.28% in the past 14 days, which was lower than the 92.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.1351, while its 200-day Moving Average is $3.8516. Nevertheless, the first resistance level for the watch stands at $1.8567 in the near term. At $1.9133, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.9567. If the price goes on to break the first support level at $1.7567, it is likely to go to the next support level at $1.7133. Assuming the price breaks the second support level, the third support level stands at $1.6567.
Fractyl Health Inc (NASDAQ: GUTS) Key Stats
There are currently 48,099K shares outstanding in the company with a market cap of 86.58 million. Presently, the company’s annual sales total 120 K according to its annual income of -77,090 K. Last quarter, the company’s sales amounted to 10 K and its income totaled -23,170 K.
